The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as
The rapid advancements in telehealth have been met with a mixture of enthusiasm and concern, especially as regulatory frameworks struggle to keep pace with technological innovations. At the center of this challenge is Mehmet Oz, the newly appointed Administrator of the Centers for Medicare
Ivan Kairatov is a recognized authority in the biopharma sector, with an extensive background in technological advancements and R&D. In this interview, Ivan shares his insights on the new FDA-approved treatment for IgA nephropathy (IgAN), shedding light on its significance in treating this rare
The U.S. Department of Health and Human Services (HHS) is experiencing a turbulent phase marked by extensive layoffs and a major reorganization under Secretary Robert F. Kennedy Jr. These moves have ignited substantial controversy and legal battles, drawing sharp reactions from various stakeholders
Innovation thrives at the intersection of regulatory flexibility and robust oversight, especially within the dynamic field of first-in-class drugs. Today, we delve into this critical topic with Ivan Kairatov, a seasoned biopharma expert with extensive experience in research and development. With a
The Healthcare Regulatory Check-Up Newsletter for February 2025 provides an in-depth overview of significant developments and updates in healthcare regulation, litigation, and policy changes in the United States. This article summarizes key settlements, legal actions, legislative proposals,
